PRIVACY POLICY | BIOSIN PHARMA
Read the Privacy Policy of Biosin Pharma. We are committed to protecting your corporate data, intellectual property, and personal information.
1. Commitment to Data Protection and Confidentiality
At Biosin Pharma, we prioritize the confidentiality of our clients’ data, intellectual property, and project specifics as highly as we prioritize our scientific research.
2. Information Collection
We collect corporate and personal information strictly for B2B communication, contract execution, and regulatory compliance. This includes data provided via contact forms, project briefs, and vendor onboarding processes.
3. Intellectual Property (IP) Protection
As a provider of Custom Synthesis and CRAMS, we operate under strict Non-Disclosure Agreements (NDAs). All proprietary information, chemical structures, and synthesis routes provided by our clients are kept in isolated, secure databases accessible only to authorized personnel.
4. Data Usage
Your information is used to:
- Provide accurate quotes and project timelines.
- Ensure compliance with international pharmaceutical regulations.
- Improve our web experience and UI/UX design.
5. Third-Party Sharing
We do not sell or rent B2B data. Information is only shared with certified third-party logistics and regulatory bodies when explicitly required for supply chain management and product delivery.
Understanding Our Data Security Practices
How does Biosin Pharma secure proprietary chemical structures and project data?
In the realm of Pharmaceutical CDMO and SCM Services, data security is synonymous with IP security. Biosin Pharma employs enterprise-grade cybersecurity measures to protect your sensitive project data, including chemical structures, analytical methods, and clinical trial quantities. Our digital infrastructure utilizes advanced encryption protocols (both at rest and in transit). Access to project-specific folders is strictly compartmentalized; only the scientists and engineers directly assigned to your project have access rights. Furthermore, our laboratories operate on secure, closed-loop networks to prevent unauthorized external access to analytical instruments and batch records, ensuring your proprietary data remains absolutely confidential.
What data is collected when I browse the Biosin Pharma website?
When you visit the Biosin Pharma website, we collect standard, non-personally identifiable analytical data to improve our UI/UX and optimize our service offerings. This includes information such as your IP address, browser type, geographic region, and the specific pages you interact with (e.g., viewing the API Impurities and Intermediates Supplier catalog). We utilize industry-standard cookies to facilitate this tracking. If you choose to submit an inquiry form, we collect the corporate contact information you explicitly provide (name, email, company, project details) to facilitate direct B2B communication and service proposals.
Does Biosin Pharma comply with international data protection regulations?
Yes, as a global pharmaceutical partner, Biosin Pharma is committed to adhering to relevant international data protection frameworks, including the principles outlined in the GDPR (General Data Protection Regulation) for our European partners, and equivalent corporate data protection laws globally. We ensure that any personal or corporate data collected is processed lawfully, transparently, and solely for the specified business purposes. Clients have the right to request access to, rectification of, or deletion of their contact information from our marketing and business development databases at any time.
Under what circumstances would Biosin Pharma share my data with third parties?
Biosin Pharma does not sell, rent, or trade your corporate data to marketing agencies or unauthorized third parties. Data sharing is strictly limited to operational necessities. For example, specific logistical data may be shared with certified, vetted third-party freight forwarders and customs brokers to facilitate global supply chain management and the physical delivery of your intermediates or APIs. Additionally, pertinent manufacturing and analytical data may be shared with international regulatory authorities (such as the FDA or EMA) strictly as part of a formal Drug Master File (DMF) submission or regulatory audit, always with the prior knowledge and consent of the client.
Contact Our Legal Department
For questions regarding these terms or to discuss a formal Service Agreement, please reach out to our registered office.
- Headquarters: Bangalore, Karnataka, India.
- Corporate Email: info@biosinpharma.com